Get In Front Of The Tsunami Of ‘New’: Introducing Brado To the OCTANe Ecosystem

There is a tsunami of ‘new’ coming in healthcare. For healthcare marketers, this is like saying there is oxygen in the air we breathe. ‘New’ is an everyday reality. So how do healthcare marketers and their organizations thrive in an environment where new – data, regulations, consolidations, technologies, opportunities, and threats keep coming in ever-increasing frequency?

The key to Get In Front of the tsunami of ‘new’ is insight. Insight can inspire the ideas and relationships that transform lives and the trajectory of health systems and medical device, pharmaceutical, biotech, and diagnostics companies. Insight is more than data; it’s data plus empathy plus intense understanding of the unstructured behaviors and needs of your customers. It’s knowing what they won’t tell you in an interview or survey or communicate in their natural language in structured environments.

Brado is an insight-driven brand growth firm that was formed specifically to help medical manufacturers and providers thrive and win in the tsunami of ‘new’. Andy Parham, Brado CEO, had the vision to put together five best-in-class healthcare marketing firms including the award-winning marketing strategy and integrated marketing communications firm DevicePharm, a longtime Orange County fixture and OCTANe contributor. DevicePharm, along with two qualitative and quantitative market research firms plus two leading search and social marketing firms form the core of Brado.

Andy Parham said, “Brado offers healthcare companies a unique opportunity to access best-in-class marketing resources across a brand’s lifecycle; from the earliest stages of market assessment and product development through integrated multi-channel brand execution. We heard from clients around the world that they want best-in-class market research, strategy, brand development, and digital marketing to be integrated. They were tired of the ball being dropped as one best-in-class firm passed their work off to the next firm in the brand lifecycle. We have solved that problem.”

Clay Wilemon, former DevicePharm CEO and now Brado Chief Strategy Officer and President of Brado Brand Activation said, “Digital Intelligence is the connective glue across Brado. Digital engagement tools for market research enable us to capture customer experience in their natural language quickly. Unstructured search and social media data enable us to know customer behaviors, priorities, and their natural language in a way that we could not know until artificial intelligence technology reached its current state. And the development of digital content and websites plus deployment of digital campaigns has advanced far beyond the bidding-up of paid advertising keywords. In short, it’s a jungle out there and digital intelligence makes us and our clients the omniscient kings of that jungle.”

Jon Hermie, former DevicePharm president and now Brado Senior Vice-President and General Manager of Brand Activation said, “The exciting thing about Brado is that we have assembled best-in-class marketing disciplines in one integrated solution for healthcare companies. DevicePharm and now Brado has been recognized as one of Medical Marketing & Media’s top Healthcare Agencies for the past decade and we received the 2019 Med-Tech Medalist award for excellence in medical technology marketing. Likewise, Evolve Media, now part of the Brado Digital Intelligence group, has been recognized as a Google Premier Partner for excellence and efficiency in paid search advertising – a designation achieved by the top 1 percent of digital marketers and only a few health-focused firms.”

Brado serves clients around the world with over 170 team members from our offices in Irvine, CA; St. Louis, MO; and Chicago, IL. You can reach us by calling 949.271.1180 or visiting our website at DevicePharm.com.